http://www.ieeta.pt/

On the 1st October 1999, the Institute of Electronics and Telematics Engineering of Aveiro (IEETA) was established in Aveiro (Portugal). It is a private non-profit-making scientific association made up of the University of Aveiro, the Fundação João Jacinto de Magalhães and the GrupUnave. Within IEETA, is the Research Unit 127/94, approved by the Portuguese Ministry of Science and Technology, which was formerly INESC - Pólo da Universidade de Aveiro.

The mission of this Institute is the following:

Multidisciplinary research and advanced development in Electronics and Telematics, integrated in the international research community and contributing to national technological and social development, being Healthcare one of the areas of intervention.

http://www.it.pt/

Instituto de Telecomunicações (it) is a private, not-for-profit organisation, of public interest, whose mission is to create and disseminate scientific knowledge in the field of telecommunications.

It has three poles in Aveiro, Coimbra and Lisbon, and delegations in Covilhã, Leiria and Porto. IT was granted the status of Associate Laboratory and gathers the expertise of more than 150 research with a PhD in areas related to telecommunications.

http://www.cmu.edu/index.shtml

Carnegie Mellon University is a global research university of more than 10,000 students, 70,000 alumni, and 4,000 faculty and staff. Recognized for its world-class arts and technology programs, collaboration across disciplines and innovative leadership in education, Carnegie Mellon is consistently a top-ranked university.

The University began as a small technical school and evolved into what it is today under the guidance of exceptional leadership teams.

http://www.biodevices.pt/

Biodevices, SA is a spin-off from IEETA (Institute of Electronics and Telematics Engineering of Aveiro / University of Aveiro) with the mission of developing, commercializing and exporting biomedical engineering solutions for medical diagnosis support.

The commitment for the continuous development of the product utility and quality have been systematically tested with extreme success on all our clinical partners considering the use of these products added value.